Home Overview Press Room Blog Publications For Students about us
Search

Inheritable Genetic Modification : Displaying 190-199 of 741


Putting Ourselves in Harm's Way: Thoughts on Pinker and the Role of Bioethicsby Nathaniel Comfort, Biopolitical Times guest contributorAugust 12th, 2015Nathaniel Comfort confronts Steven Pinker and the legacy of biomedicine, arguing ethicists and historians need to "get in harm's way to spare harm to others."
CRISPR Race Heats Up As Gates, Crossovers Put $120M Into Editas by Ben FidlerXconomyAugust 10th, 2015Some of the biggest names on Wall Street and elsewhere are handing the largest round of funding yet to a CRISPR-Cas9 startup.
Designing Life from Scratch: A Fledgling Field is About to Take Offby Lisa M. KriegerSan Jose Mercury NewsAugust 8th, 2015Scientists increasingly are designing life from scratch, using inexpensive, fast and accurate tools to create and assemble strands of DNA like tinkertoys.
The ethical and social concerns of modifying our DNA[cites CGS's Marcy Darnovsky]by Devin PowellWashington PostAugust 3rd, 2015"Scientists may be being carried away by their own enthusiasm for what they’ve developed," says Marcy Darnovsky.
'Gene Drive': Scientists Sound Alarm Over Supercharged GM Organisms Which Could Spread in the Wild and Cause Environmental Disastersby Steve ConnorThe IndependentAugust 2nd, 2015Scientists fear new technique for generating “supercharged” genetically modified organisms that can spread rapidly in the wild may be misused and cause health emergency or environmental disaster.
CRISPR/Cas Gene-Editing Technique Holds Great Promise, but Research Moratorium Makes Sense Pending Further Study by Jeff Bessen The Conversation July 29th, 2015In the enthusiasm and hype surrounding CRISPR, it is easy to forget that the technology has been in wide use for barely three years and the accompanying risks are not yet known.
The Facts Behind #CRISPRfacts and the Hype Behind CRISPRby Jonathan ChernoguzBiopolitical TimesJuly 28th, 2015WIRED's hyped CRISPR cover article triggered a wave of tweets and criticism.
Cutting-Edge Technology and Mitochondrial Diseases - Where is the Limit?by Dusko IlicBioNewsJuly 27th, 2015In their latest study, Shoukrat Mitalipov and collaborators report on two potential 'gene correction' strategies that can help patients with mitochondrial diseases.
The Power to Remake a Species[quotes CGS's Marcy Darnovsky]by Rebecca BoyleFuture of Life Institute July 23rd, 2015CRISPR could be used to eliminate malaria-carrying mosquitoes, but further public discussion is needed.
Slipping Into Eugenics? Nathaniel Comfort on the History Behind CRISPRby Elliot HosmanBiopolitical TimesJuly 23rd, 2015A historian unravels the social and political context of genetic research and eugenics in the United States.
Displaying 190-199 of 741  
< Prev  Next >> 
« First Page Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1122 University Ave, Suite 100, Berkeley, CA 94702 • • (p) 1.510.665.7760 • (F) 1.510.665.8760